Highnoon Laboratories Limited (PSX:HINOON)
Pakistan
· Delayed Price · Currency is PKR 914.79
+9.43 (1.04%)
At close: May 13, 2025
Highnoon Laboratories Income Statement
Financials in millions PKR. Fiscal year is January - December.
Millions PKR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 25,514 | 24,630 | 19,766 | 15,816 | 13,001 | 10,698 | Upgrade
|
| Revenue Growth (YoY) | 21.77% | 24.60% | 24.98% | 21.65% | 21.53% | 18.24% | Upgrade
|
| Cost of Revenue | 12,336 | 12,112 | 10,368 | 7,625 | 6,475 | 5,455 | Upgrade
|
| Gross Profit | 13,178 | 12,518 | 9,398 | 8,190 | 6,526 | 5,243 | Upgrade
|
| Selling, General & Admin | 7,360 | 6,977 | 5,720 | 4,649 | 3,985 | 3,122 | Upgrade
|
| Research & Development | 20.97 | 9.47 | 15.02 | 10.63 | 8.67 | 6.38 | Upgrade
|
| Other Operating Expenses | 526.61 | 533.91 | -46.41 | 321.04 | 219.11 | 177.04 | Upgrade
|
| Operating Expenses | 7,907 | 7,521 | 5,688 | 4,981 | 4,213 | 3,306 | Upgrade
|
| Operating Income | 5,271 | 4,997 | 3,710 | 3,209 | 2,313 | 1,937 | Upgrade
|
| Interest Expense | -402.93 | -395.03 | -149.21 | -57.07 | -27.44 | -25.73 | Upgrade
|
| Interest & Investment Income | 151.36 | 151.36 | 99.43 | 233.75 | 132.59 | 60.74 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -335.58 | -7.15 | 2.52 | -8.36 | Upgrade
|
| Other Non Operating Income (Expenses) | 38.86 | 12.94 | 45.33 | 38.79 | -2.42 | -1.57 | Upgrade
|
| EBT Excluding Unusual Items | 5,058 | 4,766 | 3,370 | 3,418 | 2,418 | 1,962 | Upgrade
|
| Gain (Loss) on Sale of Investments | 238.32 | 238.32 | -24.44 | 9.25 | 10.59 | 4.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | 27.9 | 27.9 | 13.82 | 18.17 | 6.75 | 32.07 | Upgrade
|
| Pretax Income | 5,324 | 5,032 | 3,359 | 3,445 | 2,436 | 1,999 | Upgrade
|
| Income Tax Expense | 1,790 | 1,644 | 911.61 | 972.46 | 579.32 | 525.07 | Upgrade
|
| Earnings From Continuing Operations | 3,534 | 3,389 | 2,448 | 2,473 | 1,856 | 1,474 | Upgrade
|
| Net Income | 3,534 | 3,389 | 2,448 | 2,473 | 1,856 | 1,474 | Upgrade
|
| Net Income to Common | 3,534 | 3,389 | 2,448 | 2,473 | 1,856 | 1,474 | Upgrade
|
| Net Income Growth | 34.95% | 38.44% | -1.01% | 33.20% | 25.96% | 47.29% | Upgrade
|
| Shares Outstanding (Basic) | 53 | 53 | 53 | 53 | 53 | 53 | Upgrade
|
| Shares Outstanding (Diluted) | 53 | 53 | 53 | 53 | 53 | 53 | Upgrade
|
| Shares Change (YoY) | -0.01% | - | - | - | - | - | Upgrade
|
| EPS (Basic) | 66.70 | 63.95 | 46.20 | 46.67 | 35.04 | 27.82 | Upgrade
|
| EPS (Diluted) | 66.70 | 63.95 | 46.20 | 46.67 | 35.04 | 27.82 | Upgrade
|
| EPS Growth | 34.95% | 38.44% | -1.01% | 33.20% | 25.96% | 47.29% | Upgrade
|
| Free Cash Flow | 4,010 | 4,143 | 883.21 | -1,237 | 1,430 | 1,038 | Upgrade
|
| Free Cash Flow Per Share | 75.68 | 78.20 | 16.67 | -23.34 | 26.99 | 19.59 | Upgrade
|
| Dividend Per Share | 40.000 | 40.000 | 30.000 | 15.810 | 14.373 | 9.800 | Upgrade
|
| Dividend Growth | 33.33% | 33.33% | 89.75% | 10.00% | 46.67% | 26.92% | Upgrade
|
| Gross Margin | 51.65% | 50.82% | 47.55% | 51.79% | 50.20% | 49.01% | Upgrade
|
| Operating Margin | 20.66% | 20.29% | 18.77% | 20.29% | 17.79% | 18.11% | Upgrade
|
| Profit Margin | 13.85% | 13.76% | 12.38% | 15.63% | 14.28% | 13.78% | Upgrade
|
| Free Cash Flow Margin | 15.72% | 16.82% | 4.47% | -7.82% | 11.00% | 9.70% | Upgrade
|
| EBITDA | 5,549 | 5,252 | 3,908 | 3,392 | 2,480 | 2,066 | Upgrade
|
| EBITDA Margin | 21.75% | 21.32% | 19.77% | 21.45% | 19.08% | 19.31% | Upgrade
|
| D&A For EBITDA | 278.52 | 254.82 | 198.44 | 182.75 | 166.87 | 128.81 | Upgrade
|
| EBIT | 5,271 | 4,997 | 3,710 | 3,209 | 2,313 | 1,937 | Upgrade
|
| EBIT Margin | 20.66% | 20.29% | 18.77% | 20.29% | 17.79% | 18.11% | Upgrade
|
| Effective Tax Rate | 33.62% | 32.67% | 27.14% | 28.23% | 23.78% | 26.27% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.